Thus, it would be interesting to analyze whether the ATM, ATR, and DNA-PKcs mutations observed in COAD inhibit the dissociation of the MDM2–p53 protein complex, and thus p53 stabilization and activation. The gene discussed is TP53; the disease is colon adenocarcinoma.